Download PDF
NOTARZT 2003; 19(3): 105-109
DOI: 10.1055/s-2003-39535
Originalia
© Georg Thieme Verlag Stuttgart · New York

Prähospitale Thrombolyse bei Patienten mit akutem Herzinfarkt - Schon Routine oder noch die Ausnahme?

Ergebnisse einer Umfrage der Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)Prehospital Thrombolysis in Patients with Acute ST Elevation Myocardial Infarction - Fact or Fiction? Results of a Survey of the Arbeitsgemeinschaft Leitende Kardiologische KrankenhausärzteU.  Zeymer1 , R.  Zahn1 , U.  Tebbe2 , J.  Senges1
  • 1Medizinische Klinik B, Herzzentrum Ludwigshafen
  • 2Medizinische Klinik II, Klinikum Lippe-Detmold
Further Information

Publication History

Publication Date:
27 May 2003 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die frühe Anwendung einer Reperfusionstherapie führt bei Patienten mit akutem ST-Hebungsinfarkt zur Verringerung der Mortalität und Morbidität. Mit der prähospitalen Thrombolyse kann eine um 30 - 90 Minuten frühzeitigere Einleitung der thrombolytischen Therapie gegenüber der intrahospitalen Behandlung erreicht werden. Voraussetzungen zur Durchführung der prähospitalen Thrombolyse sind ein 12-Kanal-Elektrokardiogramm, zusätzlich zu einer kontinuierlichen Monitorüberwachung und die Möglichkeit zur Defibrillation. In einer Umfrage an 90 Kliniken der ALKK ergab sich, dass die Möglichkeit zur Registrierung eines 12-Kanal-EKGs im Notarztwagen in 65 (72 %) Notarztsystemen gegeben ist. Eine prähospitale Thrombolyse wird momentan bei 23 (25 %) durchgeführt und ist bei weiteren 20 (22 %) Notarztsystemen geplant. Der momentane Stand der prähospitalen Versorgung des akuten Herzinfarkts wird in einem gemeinsamen bundesweiten Register (PREMIR) der ALKK und der BAND erfasst werden.

Abstract

The early initiation of reperfusion therapy in patients with acute ST elevation myocardial infarction is associated with in improvement in clinical outcome. The prehospital initiation of thrombolysis can reduce the time interval between symptom onset and start of therapy between 30 and 90 minutes. Prerequisites for prehospital thrombolysis are a 12-lead ECG, in addition to a continuous ECG monitoring and an external defibrillator. Of 90 ambulance systems related to hospitals of the ALKK 72 % are equipped with a 12-lead ECG, prehospital thrombolysis is currently performed in 25 % and planned in another 22 %. The current status of prehospital therapy in patients with acute ST elevation myocardial infarction in Germany will be evaluated in a nationwide registry (PREMIR).

Schlüsselwörter

Akuter Herzinfarkt - Thrombolyse - prähospitale Therapie - adjuvante Therapie - Register

Key words

Acute myocardial infarction - thrombolysis - prehospital therapy - adjuvant therapy - registry

Literatur

  • 1 White H D, Van de Werf F JJ. Thrombolysis for acute myocardial infarction.  Circulation. 1998;  97 1632-1646
    PubMedGoogle Scholar
  • 2 Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R,. the ISIS-2 Collaborative Group . ISIS-2: 10-year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither.  BJM. 1998;  316 1337-1343
    PubMedGoogle Scholar
  • 3 Franzosi M G, Santoro E, De Vita C, Geraci E, Lotto A, Maggioni F, Rovelli F, Santoro L, Tavazzi L, Tognoni G,. on behalf of the GISSI Investigators . Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction.  Circulation. 1998;  98 2659-2665
    PubMedGoogle Scholar
  • 4 Vogt A, von Essen R, Tebbe U, Feuerer W, Appel K F, Neuhaus K L. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies.  J Am Coll Cardiol. 1993;  21 1391-1395
    PubMedGoogle Scholar
  • 5 FTT Fibrinolytic Therapy Trialists' (FTT) Collaborative Group . Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients.  Lancet. 1994;  343 311-322
    PubMedGoogle Scholar
  • 6 The GUSTO Angiographic Investigators . The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction.  N Engl J Med. 1993;  329 1615-1620
    CrossrefPubMedGoogle Scholar
  • 7 Neuhaus K L, Feuerer W, Jeep-Tebbe S, Niederer W, Vogt A, Tebbe U. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.  J Am Coll Cardiol. 1989;  14 1566-1569
    CrossrefPubMedGoogle Scholar
  • 8 Zeymer U, Neuhaus K L. New Thrombolytic agents. In: Cannon CP (ed) Management of Acute Coronary Syndromes. Totowa, USA; Humana Press 1998: 243-265
    Google Scholar
  • 9 Morrow D A, Antman E M, Sayah A. et al . Evaluation of time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction.  J Am Coll Cardiol. 2002;  40 71-77
    CrossrefPubMedGoogle Scholar
  • 10 Fath-Ourdoubadi F, Al-Mohammed A, Huehns T Y. et al . Meta-analysis of randomised trials of prehospital versus hospital thrombolysis.  Circulation. 1994;  90 I-325
    PubMedGoogle Scholar
  • 11 Bonnefoy E, Lapostolle F, Leizorovicz A. et al . Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.  Lancet. 2002;  360 825-829
    CrossrefPubMedGoogle Scholar
  • 12 Arntz H R, Tebbe U, Schuster H P. et al . Leitlinien zur Diagnostik und Therapie des Herzinfarkts in der Prähospitalphase.  Z Kardiol. 2000;  89 364-372
    CrossrefPubMedGoogle Scholar
  • 13 The European Myocardial Infarction Project Group . Prehospital thrombolytic therapy in patients with suspected myocardial infarction.  N Engl J Med. 1993;  329 383-389
    CrossrefPubMedGoogle Scholar
  • 14 Zeymer U. Stellenwert der Bolus-Fibrinolytika zur Therapie des akuten Herzinfarkts.  Dtsch Med Wschr. 2002;  127 2083-2086
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 The GUSTO III Investigators . A comparison of reteplase with alteplase for acute myocardial infarction.  N Engl J Med. 1997;  337 1118-1123
    CrossrefPubMedGoogle Scholar
  • 16 ASSENT-2 Investigators . Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction. The ASSENT-2 double blind randomised trial.  Lancet. 1999;  354 716-722
    CrossrefPubMedGoogle Scholar
  • 17 Giugliano R P, McCabe C H, Antaman E M. et al . Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.  Am Heart J. 2001;  141 742-750
    CrossrefPubMedGoogle Scholar
  • 18 The ASSENT-3 Investigators . Efficacy and safety of tenecteplase in combination with enoxaparin. Abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.  Lancet. 2001;  338 605-613
    PubMedGoogle Scholar
  • 19 Zeymer U. Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: Will the combination with thrombolytics become reality?. J Thrombosis Thrombolysis 2002 im Druck
    Google Scholar
  • 20 The GUSTO V Investigators . Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.  Lancet. 2001;  357 1905-1914
    CrossrefPubMedGoogle Scholar
  • 21 Genzwürker H, Isovic H, Finteis T. et al . Ausstattung von Notarzt-besetzten Rettungsmitteln in Baden-Württemberg.  Anästhesist. 2002;  51 367-373
    CrossrefPubMedGoogle Scholar
  • 22 Canto J G, Rogers W J, Bowlby L J. et al . The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized?.  J Am Coll Cardiol. 1997;  29 498-505
    PubMedGoogle Scholar

Priv.-Doz. Dr. Uwe Zeymer

Herzzentrum Ludwigshafen · Medizinische Klinik B

Bremserstraße 79

67063 Ludwigshafen

Email: Uwe.Zeymer@t-online.de

      >